首页> 外国专利> hybridzellinie to produce monoclonal antikoerper against a human thymozytantigen, antikoerper and procedures to its production, diagnostic and therapeutic uses, and pharmaceutical compositions containing these antikoerper.

hybridzellinie to produce monoclonal antikoerper against a human thymozytantigen, antikoerper and procedures to its production, diagnostic and therapeutic uses, and pharmaceutical compositions containing these antikoerper.

机译:用于产生抗人胸腺抗原的单克隆抗库珀的杂交杂种,抗库珀及其生产,诊断和治疗用途的程序以及含有这些抗库珀的药物组合物。

摘要

Hybrid cell line for production of monoclonal antibody to an antigen found on approximately 70% of normal human thymocytes. The hybrid is formed by fusing splenocytes from immunized CAF1 mice with P3X63Ag8U1 myeloma cells. Diagnostic and therapeutic uses of the monoclonal antibody are also disclosed.
机译:用于产生针对大约70%的正常人胸腺细胞中发现的抗原的单克隆抗体的杂交细胞系。该杂种是通过将来自免疫CAF1小鼠的脾细胞与P3X63Ag8U1骨髓瘤细胞融合而形成的。还公开了单克隆抗体的诊断和治疗用途。

著录项

  • 公开/公告号AT12660T

    专利类型

  • 公开/公告日1985-04-15

    原文格式PDF

  • 申请/专利权人 ORTHO PHARMACEUTICAL CORPORATION;

    申请/专利号AT19800304347T

  • 发明设计人 KUNG PATRICK CHUNG-SHU;GOLDSTEIN GIDEON;

    申请日1980-12-03

  • 分类号C12P1/00;C12N5/00;C12N15/00;G01N33/50;A61K39/395;

  • 国家 AT

  • 入库时间 2022-08-22 08:07:51

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号